Yes, Invitae does offer pre-authorizations for insurance billing within the United States. For more information, please see the pre-authorization forms on the Forms page or contact Client Services. Regardless of whether a patient is in-network or out-of-network, Invitae is committed to making genetic testing affordable.
Diagnostic panel testing and carrier screening
Typically patients pay no more than $100 out of pocket for one of our panel or single-gene tests. If a patient receives a bill for more than $100, the patient can call us to discuss payment options. Invitae also has a Patient Assistance Program that may apply in these situations.
For exome testing, we will conduct a benefits investigation (BI) on every order and manage the prior authorization process. Patients will be contacted if their out-of-pocket responsibility is greater than $100 or if the authorization request is denied. We will inform the patients of their options including payment plans, pre-payment, and canceling the test. If the patient opts to cancel, we will contact the clinician. Note that we do not offer BIs before an order is placed nor do we accept Medicare (including managed Medicare) or Medicaid (including managed Medicaid) for exome testing at this time.
If you are considering ordering microarray testing but are concerned about the in-network out-of-pocket cost for a particular patient, please contact our Client Services team. We can conduct a benefits investigation (BI) upon request.